Cases of appendix cancer, a rare gastrointestinal malignancy, are increasing significantly among younger adults, according to new research published June 10 in Annals of Internal Medicine. The study reveals that individuals born in the 1960s through the 1980s—primarily Gen Xers and older Millennials—face a three- to fourfold higher risk of developing the disease compared to those born in the 1940s.
Though appendix cancer remains exceedingly rare—impacting roughly one to two individuals per million annually—experts are concerned by its growing incidence among younger populations. The trend echoes broader patterns in early-onset cancers, such as colorectal cancer, which are also becoming more common in adults under 50.
“Compared to those born in the 1940s, Gen X and older Millennials are around three times more likely to be diagnosed with appendix cancer overall. That was quite striking to us,” said lead author Andreana N. Holowatyj, PhD, MS, an assistant professor of hematology and oncology at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center.
Read More: Why Certain AI Models Emit 50x More Greenhouse Gases for the Same Answer
Holowatyj noted that the rise in appendix cancer parallels increases seen in other gastrointestinal cancers, prompting new questions about environmental, genetic, or lifestyle factors that may be contributing to the shift.
“Seeing these parallel effects across other GI cancers really makes us raise an eyebrow as to what etiologies are underpinning these alarming and worrisome trends,” she told Healthline.
While appendix cancer remains understudied and lacks established screening guidelines, the findings underscore the need for greater awareness—particularly among healthcare providers and younger patients.
“This is a real phenomenon that we’re noticing,” said Kiran Turaga, MD, MPH, chief of surgical oncology at the Yale School of Medicine, who was not involved in the study. “Just last week in clinic, I saw 18-year-olds and 20-year-olds with appendix cancer.”
Because routine screening is not recommended for this rare malignancy, experts emphasize the importance of promptly discussing any unexplained abdominal symptoms with a physician.
Appendix Cancer Risk 3 to 4 Times Higher in Gen X and Millennials, Study Finds
A new study has identified a striking rise in appendix cancer among younger generations, particularly those born between 1975 and 1985. According to data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program, this group faces a three- to fourfold higher risk of developing the disease compared to individuals born in the 1940s.
Researchers analyzed 4,858 cases of appendix cancer diagnosed in adults aged 20 and older between 1975 and 2019. Their analysis revealed a consistent annual increase in incidence beginning with those born after 1945—an upward trend that experts say cannot be explained solely by better imaging or detection methods.
“This is not just a phenomenon of increased detection,” said Dr. Kiran Turaga, MPH, chief of surgical oncology at Yale School of Medicine. “Just looking at the magnitude of these numbers, combined with what we’re seeing in our clinics and what we understand about our patients, I do believe that this is a true phenomenon of increasing incidence—especially in younger adults.”
An Understudied and Often Overlooked Cancer
Though appendix cancer remains rare—accounting for fewer than 1% of all gastrointestinal cancers—it is gaining attention as part of a broader trend of early-onset malignancies. Historically, appendix tumors were misclassified as right-sided colon cancers, which limited research and masked their unique biological characteristics.
“In many cases, appendix cancer is discovered incidentally after an appendectomy,” explained Dr. Andreana Holowatyj, PhD, MS, the study’s lead author and an assistant professor at Vanderbilt University Medical Center. “Only recently have we begun to understand that appendix tumors differ biologically from colon tumors, which really highlights the need for dedicated research.”
Currently, there are no FDA-approved treatments specific to appendix cancer. As a result, clinical guidelines typically treat it as a subtype of colon cancer—despite growing evidence that the two require distinct approaches.
A Broader Pattern of Rising Early-Onset Cancers
The rise in appendix cancer mirrors an alarming pattern seen across various cancers in young adults. A 2024 study published in Lancet Public Health found that Millennials are at heightened risk for 17 types of cancer, including breast, uterine, colorectal, stomach, testicular, and ovarian cancers.
Researchers have yet to identify a single cause driving this increase. Instead, experts believe it’s likely the result of a complex interplay of lifestyle and environmental factors.
“It’s not going to come down to just one thing,” Holowatyj said. “We’re looking at a constellation of influences—from rising obesity rates and physical inactivity to dietary changes, gut microbiome disturbances, and exposure to microplastics and air pollution.”
Dr. Turaga also pointed to potential links to antibiotic use and ultra-processed foods, though he emphasized that current evidence is still inconclusive.
Emerging Concerns in Appendicitis Treatment
One potential complication in diagnosing appendix cancer stems from evolving treatment protocols for appendicitis. Increasingly, physicians opt to treat appendicitis with antibiotics rather than surgery—an approach that may delay or miss cancer diagnoses altogether.
“If a tumor is present and you treat appendicitis conservatively with antibiotics, that’s a missed opportunity for early detection,” Holowatyj said.
Appendix Cancer Symptoms and the Importance of Vigilance
There are currently no standardized screening protocols for appendix cancer, and even colonoscopies—which are highly effective for colorectal cancer—can fail to detect tumors in the appendix.
Given the lack of routine screening, physicians urge increased awareness of subtle symptoms. Dr. Yun Song, a surgical oncologist at MD Anderson Cancer Center, recommends paying attention to persistent abdominal discomfort, unexplained weight loss, bloating, or early satiety. In women, symptoms may be mistaken for gynecological conditions.
Common signs of appendix cancer, according to the National Cancer Institute, include:
- Abdominal pain or discomfort
- A palpable mass in the abdomen
- Nausea and vomiting
- Bloating or visibly increased abdominal size
- Feeling full quickly while eating
“Despite the rising incidence, appendix cancer remains rare, and not all abdominal symptoms indicate cancer,” Dr. Song said. “However, knowing your family history is crucial—multiple relatives with cancer may suggest a higher genetic risk.”
Frequently Asked Questions
Is appendix cancer really increasing in young adults?
Yes. Recent research shows a significant rise in appendix cancer rates among Gen Xers and Millennials. People born between 1975 and 1985 are 3 to 4 times more likely to develop the disease compared to those born in the 1940s.
How common is appendix cancer?
Appendix cancer is rare, affecting roughly 1 to 2 people per million each year. It accounts for less than 1% of all gastrointestinal cancers.
Why is appendix cancer often diagnosed late?
Because it is so rare, it’s not commonly screened for, and its symptoms are often mistaken for other conditions. Additionally, the growing use of antibiotics instead of surgery for appendicitis may delay diagnosis in some cases.
Can appendix cancer be detected by a colonoscopy?
Not reliably. Although colonoscopy is effective for detecting colorectal cancer, it often misses appendix tumors due to their location.
Is there any way to screen for appendix cancer?
Currently, there is no standard screening test. Awareness of persistent or unusual abdominal symptoms is key, especially in individuals with a family history of cancer.
How is appendix cancer treated?
Treatment typically involves surgery, and in some cases, chemotherapy. However, because there are no FDA-approved therapies specific to appendix cancer, it is often treated similarly to right-sided colon cancer—even though the two may differ biologically.
Should I be worried if I have abdominal pain?
Not necessarily. Most abdominal pain is not caused by cancer. However, if you have persistent symptoms, unexplained weight loss, or a family history of cancer, it’s important to speak with your doctor.
Conclusion
Although appendix cancer remains a rare diagnosis, its rising incidence among younger generations—particularly Gen Xers and Millennials—underscores an urgent need for increased awareness, further research, and improved diagnostic strategies. As evidence continues to highlight a broader trend of early-onset cancers, healthcare professionals and patients alike must remain vigilant.
With no standard screening protocols and often subtle or misattributed symptoms, early detection of appendix cancer can be challenging. Recognizing persistent abdominal issues and discussing family history or unusual symptoms with a physician may help identify cases earlier and improve outcomes.